<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">112</article-id><article-id pub-id-type="doi">10.36691/RJA112</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">About the role of bacteria in patients with bronchial asthma, chronic obstructive pulmonary disease and ACOS</article-title><trans-title-group xml:lang="ru"><trans-title>К вопросу о роли бактерий у больных бронхиальной астмой, хронической обструктивной болезнью легких и ACOS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedoseev</surname><given-names>G B</given-names></name><name xml:lang="ru"><surname>Федосеев</surname><given-names>Г Б</given-names></name></name-alternatives><bio xml:lang="ru"><p>член-корр. РАН, з.д.н. России, доктор медицинских наук, профессор кафедры госпитальной терапии им. акад. М.В. Черноруцкого</p></bio><email>fedoseevsp@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trofimov</surname><given-names>V I</given-names></name><name xml:lang="ru"><surname>Трофимов</surname><given-names>В И</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, зав. кафедрой госпитальной терапии им. акад. М.В. Черноруцкого</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golubeva</surname><given-names>V I</given-names></name><name xml:lang="ru"><surname>Голубева</surname><given-names>В И</given-names></name></name-alternatives><bio xml:lang="ru"><p>биолог лаборатории клинической иммунологии и молекулярной диагностики</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Timchik</surname><given-names>V G</given-names></name><name xml:lang="ru"><surname>Тимчик</surname><given-names>В Г</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, врач функциональной диагностики отделения функциональной диагностики № 2 научно-клинического исследовательского центра</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Negrutsa</surname><given-names>K V</given-names></name><name xml:lang="ru"><surname>Негруца</surname><given-names>К В</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры госпитальной терапии им. акад. М.В. Черноруцкого</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Razumovskaya</surname><given-names>T S</given-names></name><name xml:lang="ru"><surname>Разумовская</surname><given-names>Т С</given-names></name></name-alternatives><bio xml:lang="ru"><p>ведущий инженер отделения функциональной диагностики № 2 научно-клинического исследовательского центра</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aleksandrin</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Александрин</surname><given-names>В А</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры госпитальной терапии им. акад. М.В. Черноруцкого</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kryakunov</surname><given-names>K N</given-names></name><name xml:lang="ru"><surname>Крякунов</surname><given-names>К Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры госпитальной терапии им. акад. М.В. Черноруцкого</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The M.V. Chernorutsky Department of Hospital Therapy of the Pavlov First State Medical University of St. Petersburg</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-12-14" publication-format="electronic"><day>14</day><month>12</month><year>2018</year></pub-date><volume>15</volume><issue>6</issue><issue-title xml:lang="en">NO6 (2018)</issue-title><issue-title xml:lang="ru">№6 (2018)</issue-title><fpage>65</fpage><lpage>78</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Фармарус Принт Медиа</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2020-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/112">https://rusalljournal.ru/raj/article/view/112</self-uri><abstract xml:lang="en"><p>The article deals with bacterial lung microbiota in patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD), bacterial inflammation of the bronchopulmonary system which can be manifested by sensitization and allergy. Also they can be a trigger with the development of bacterial inflammation. Bacteria can colonize the lungs without severe clinical, laboratory and instrumental changes. High levels of IgG to Str. pneumoniae, Neisseria perflava, Haemophilus influenza in ACOS patients can be evidence of their etiological significance. Taking into account the etiological significance of microbiota, methods of treatment of patients with COPD and BA with the use of antibiotics, vaccines and probiotics have been developed.</p></abstract><trans-abstract xml:lang="ru"><p>В статье рассматривается бактериальная микробиота легких у больных бронхиальной астмой (БА) и хронической обструктивной болезнью легких (ХОБЛ). Бактерии формируют воспаление бронхолегочного аппарата, которое может проявляться сенсибилизацией и аллергией, быть триггером с развитием бактериального воспаления. Бактерии могут колонизировать легкие без выраженной клинической, лабораторной и инструментальной симптоматики. У больных ACOS высокие уровни IgG к Streptococcus pneumoniae, Neisseria perflava, Haemophilus influenzae свидетельствуют об их этиологической значимости. С учетом этиологической значимости микробиоты разрабатываются методы лечения больных ХОБЛ и БА с использованием антибиотиков, вакцин и пробиотиков.</p></trans-abstract><kwd-group xml:lang="en"><kwd>ACOS</kwd><kwd>bronchial asthma</kwd><kwd>chronic obstructive pulmonary disease</kwd><kwd>acos</kwd><kwd>microbiota</kwd><kwd>inflammation</kwd><kwd>treatment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>бронхиальная астма</kwd><kwd>хроническая обструктивная болезнь легких</kwd><kwd>микробиота</kwd><kwd>воспаление</kwd><kwd>лечение</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. Allergy Clin Immunol. 2011;127:372-381.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Beck JM, Young VB, Huffnaagle GB. The microbiome of lung. Transl Res. 2012;160:258-266.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wang L, Hao K, Jang T, Wang C. Role of lung microbiota in the pathogenesis of chronic obstructive pulmonary disease. Chin Med J. (Engl.). 2017;130:21072111.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Lieberman D, Peintz S. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am Respir Crit Care Med. 2003;167:406-410.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ntwcomb DC. Stokes Peebles IR Bugs and asthma. A different disease? Proc Am Thorac Soc. 2009;6:266-271.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Dickson RP Huffnagle GB. The Lung Microbiome: New Principles for Respiratory in Health and Disease. PLos Pathog. 2015;11:e1004923.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Schmidt A, Belaaouaj A, Bissinger R, Koller G, Malleret L, Orazio C at al. Neutrophil elastase-mediated incrise in airway temperature during inflammation. J Cyst Fibros. 2014;1:623-631.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Dickson RP, Marninez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384:691-702.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mammen MJ, Sethi S. COPD and microbiome. Respirology. 2016;21:590-599.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Fujimura KE, Lynch SV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe. 2015;17:592-602.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Smolinska S, Groeger D, O’Mahony L. Biology of the microbiome: interactions with the host immune response. Gastroenterol Clin N Am. 2017;46:19-35.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>O’Dwyer DR, Dickson RP, Moore BB. The lung microbiome, immunity, and the pathogenesis of chronic lung disease. J Immunol. 2016;196:4839-4847.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes trend in school age. Clin Exp Allergy. 2014;44:842850.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Liu AN, Leung DIM. Renessance of the hygiene hypothesis. J Allergy Clin Immunol. 2006;117:1063-1066.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hirsch T, Range U, Walther KU, Haderer B, Lassing S, Frey G, Leupold W Prevalence and determinants of house dust mite allergen in East German homes. Clin Exp Allergy. 1998;28:956-964.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010;10:861-868.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Barnes KC. Genetic studies of the etiology of asthma. Proc Am Thorac Soc. 2011;8:143-148.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Blaser MN, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887-894.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Mirobiol Rev. 2009;22:240-273.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Fowler SJ, Tavernier G, Neven R. High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma. J Allergy Clin Immunol. 2015;135:822-824.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Riedel J, Brau-Fehrlander C, Eder W Schreuer M, Waser M, Maisch S et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358:1129-1133.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol. 2006;117:969-977.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hugg TT, Jaakkola MS, Ruotsalainen R, Pushkarev V, Jaakkola JJ. Exposure to animals and risk of allergic asthma: a population-based cross-sectional study in Finnish and Russian children. Environ Health. 2008;7:28.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Thavagnanam S. A meta-analysis of the association between Caesarean section and childhood asthma. Clin Exp Allergy. 2008;38:629-633.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Ege ML. Exposure to Environmental Microorganisms and Childhood Asthma. N Engl J Med. 2011;364:701-709.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Edwards ML, Bartlett NW, Hussel T Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Micro. 2012;10:459-471.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Kozlov R et al. disease in Central and Eastern Europe, and Israel. Cent Eur J Health. 2012;20:121-125.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Jackson ML, Nelson JC, Jackson LA. Risck factors for community-acquired pneumonia in immunocompetent seniors. J A Geriatr Soc. 2009;57:882-888.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Juthani-Mehta M, De RN, Allor H, Chen S, O’Leary JR, Bauer DC et al. Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: the Health, Aging, and Body Composition Study. J Am Geriatr Soc. 2013;61:1111-1118.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Gau JT, Acharya U., Khan S., Heh V., Mody L., Kao TC. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr. 2010;10. DOI: 10.1186/1471-2318-10-45.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Inghammar M., Engstrom G., Kahlmeter G., Ljungberg B., Lofdahl CG, Egtsten A. Invasive pneumococcal disease underlying pulmonary disorder. Clin Microbiol Infect. 2013;19:1148-1154.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Булатов П.К. Бронхиальная астма. Медицина. 1964:325</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Адо АД, Булатов П.К. Клинико-физиологические основы классификации бронхиальной астмы. Материалы V. межобл. научн. конф. терапевтов «Этиология, патогенез, клиника и лечение заболеваний органов дыхания». Л., 1969:258-265</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Адо А.Д. Современные проблемы аллергических реакций. Вестн. АМН СССР. 1979;1:34-43</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Адо АД, Федосеева В.Н. Роль нейссерий в этиологии и патогенезе бронхиальной астмы. Клин вед. 1980;4:24-28</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Scottish Intercollegiate Guidelines Network and British Thoracic Society (2014) British the management of asthma. Thorax 69 Suppl 1, il-i195.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Dulek DE, Peebles RS. Bacteria and asthma: more there than we thought. Expert Rev Respir Med. 2911;5:329-332.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Marri PR, Stern DA, Wright AL, Billheimer D., Martinez FD. Asthma-associated differ microbial composition of induced sputum. J. Allergy Clin Immunol. 2013;131:346-352.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Rogers GB, Shaw D., March RL, Carroll ML, Serisier DJ, Brucce KD. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax. 2015;70:74-81.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Han MK. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67:436-463.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Arman J., von Mutius E. Do bacteria have role in asthma development. Eur Resp J. 2010;36:469-471.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Green BJ. Potentially pathogic airway bacteria and neutrophilic inflammation in treatmеnt resistant severe asthma. PLoS ONE. 2014;9:t100645.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Simpson JL, Dali J., Baines KL, Yang IA, Upham IW, Reynolds PN et al. Hemophilis influenza and Tropheryma in poorly controlled asthma. Eur Resp J. 2016;47:792-800.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Earl CS, Keong, Shi-qi An, Murdoch S., McCarthy, Garmendia J. et al. Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance. EMBO Mol Med. 2010;7:1018-1033. 4 5. Guilbert TW, Denlinger LC. Role of infection in the development and exacerbation of asthma. Expert Rev Respir Med. 2010;4:71-83.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Joung JJ. Risk for infection in patients with asthma (or other atopic condition): Is asthma more than a chronic airway disease? J. Allergy Clin Immunol. 2014;134:247-257.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Nisar N., Guleria R., Kumar S. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J. 2007;83:100-104.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Korppi M. Management of bacterial infections in children with asthma. Expert Rev Anti Infect Ther. 2009;7:869-877.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Iikura M., Hojo M., Koketsu R., Watanabe S., Sato A., Chino H. et al. The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice. PLOS One. 2015;10(4):e0123584. Published online 2015 Apr</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>DOI: 10/1371/journal.pone. 0123584.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Harju TH, Leinonen M., Nokso-Koivisto J., Korhonen T., Raty R., He Q. et al. Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax. 2006;61:579-584.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Huang YJ, Nariya S., Harris YM, Lynch SV, Choy DF, Arron YR, Boushey H. The Airway Microbiome in Severe Asthma: Associations with Disease Features and Severity. J. Allergy Clin Immunol. 2015;136:874-884.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Hahn DL. Infections asthma: a reemerging clinical entity? J. Fam Pract. 1995;41:153-157.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Halablab MA, Hijazi SM, Fawzi MA, Ara GF. Staphylococcus aureus nasal carriage rate and associated risk factors in individuals in community. Epidemiol Infection. 2010;138:702-706.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Jackson DJ, Tern JE, Lemanske RF. The contributions of allergic sensitization and respiratory pathogens to asthma inception. Allergy Clin Immunol. 2016;137:659-665.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Корчева ЕГ, Печкуров Д.В. Особенности бронхиальной астмы у детей при бактериальной контаминации верхних дыхательных путей. Прaкт медицина. 2011;5(11)</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Novak N., Bieber T. Allergic and nonallergic forms of atopic diseases. J. Allergy Clin Immunol. 2003;112:252-262.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Hilty M., Burke C., Pedro H., Cardenas P., Bush A., Bossley C. et al. Disordered microbial communities in asthmatic airways. PLos One. 2015;5(1):е8578. DOI: 10.1371/journal. pone.0008578.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Huang Y., Sethi S., Murphy T., Nariya S., Boush HA, Lynch SV. Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease. J. Clin Microbiol. 2014;52:2813-2823.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Bisgaard H., Hermansen MN, Buchvald F., Loland L., Halkjaer LB, Bonnelykke K. et al. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl J. Med. 2007;357:1487-1495.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Larsen JM, Brix S., Thysen AH, Birch S., Rasmussen MA, Bisgaard H. Children with asthma by school age display aberrant immune responses to pathogenic airway bacteria as infants. J. Allergy Clin Immunol. 2014;133:1008-1013.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Brikey WJ Alexis NE, Hernander ML, Reed W., Ting JP, Peden DB. Sputum inflammatory cells from persons with allergic rhinitis and asthma have decreased inflammasome gene expression. J. Allergy Clin Immunol. 2011; 128(4):900-903. DOI: 10.1016/j.jaci.2011.08.012/.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Zhang Q., Illing R., Hyi CK, Downey K., Carr D., Stearn M. et al. Bacteria in sputum of stable severe asthma and increased airway wall thickness. Respiratory Research. 2012;13:35-39.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Walk P., Tooze M., Powell H., Parsons K. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013. DOI: 10.1111\resp. 12099.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Juhn I. Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease? J. Allergy Clin Immunol. 2014;134:247-257.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Федосеева ВН, Молотилов БА, Ларина ОН, Федоскова Т.Г. Бактериальная аллергия. Пенза. 2004:213</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Федосеев ГБ, Трофимов ВИ, Ровкина ЕИ и соавт. Бронхиальная астма и инфекция: диагностика и принципы лечения. Пульмонология. 2008;5:86-94</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Durack J., Lynch, Nriya S., Bhakta NR, Beigelman A., Castro et al. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J. Allergy Clin Immunol. 2017;140:63-75. DOI: 10.101.1016/j.jaci/2016.08.055.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Bachert C., van Steen K., Zhang N., Holtappels G., Cattaert T., Maus B. et al. Specific IgE against Staphylococcus aureus enterotoxins: an indepenponsivenesdent risk factor for asthma. J. Allergy Clin Immunol. 2012;130:376-381.</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3:948-958.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Chavakis T., Hissain M., Kanse SM, Peters G., Bretzel RG, Flock JI et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med. 2002;8:687-693.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Maresso AW, Schneewind O. Iron acquisition and transport in Staphylococcus aureus. Biometals. 2006;19:193-203.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Regev-Yochay G., Trzcinski K., Thompson C., Malley R., Lipsitch M. et al. Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J. Bacteriol. 2006;188:4996-5001.</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Anto JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagara X et al. Understanding the complexity of IgE-related phenotypes from childhood to yong adulthood: mechanisms of the development of allergy (MeDALL) seminar. J Allergy Clin Immunol. 2012;129:943-954.</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Benoit M., Desnues B., Mege JL. Macrophage polarization in bacterial infection. J. Immunol. 2008;181:3733-3739.</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Price L., Graham KJ, Connolly J., Anwar S., Ridley R., Sabroe I. et al. Staphylococcus aureus induced eosinophil cell death mediated by alfa-hemolysin. Plos One. 2012;7(2):е31506. DOI: 10.1371./journal.pone.0031506.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Bachert C., Gevaert P., Holtappels G., Holtappels G., van Cauwenberge P., Johansson SG. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J. Allergy Clin Immunol. 2003;111:1131-1132.</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Hermann I., Rath S., Ziesemer S., Volksdorf T., Dress RJ, Gutjahr M. et al. Staphylococcus aureus Hemolysin A diprupts cell-matrix adhesions in human airway epithelial cells. Amer J. Respir Cell Mol Biol. 2015;52:14-24.</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Torrent M., De la Torre BG, Nogues MV, Andreu D., Boix E. Bactericidal and membrane disruption activities of the eosinophil cationic protein and largely retained in an N-terminal fragment. Biochem J. 2009;421:425-434. DOI: 10.1042/BJ20082330.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Hentschke I., Graser A., Melichan VO, Kiefer A., Zimmermann T., Kros B. et al. IL-33/ST2 immune response to respiratory bacteria in pediatric asthma. Sci Reports. 2017;7:43426. DOI: 10.1038/srep43426.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Hardt WD. Antibiotics: Homed to the hideout. Nature. 2015;527:309-310. DOI: 10ю 1038/nature 15647.</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Wood-Jung Song, Eun-Jung Jo, Ji-Won Lee, Hye-Ryun K., Sang-Heon Cho, Kyung-Up Min, Yoon-Seok Chang. Staphylococcal enterotoxin specific IgE and asthma: a systematic review. Asia Pac Allergy. 2013;3:120-126.</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Corriveau MN, Zhang N., Holtappels G., Van Roy N., Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J. Rhinol Allergy. 2009;3:461-465. DOI: 10.2500/ajra.2009.23.3367.</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Deryke L., Perez-Novo C., Van Crombruggen K., Corriveau MN, Bachen C. Staphylococcus aureus and chronic airway disease. World Allergy Organ J. 2010;3:223-228.</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Harvey RL, Wallwork BD, Lund VJ. Anti-inflammatory effect of macrolides: Applications in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;3:689-703.</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Sethi S., Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-Art Review. Clin Microbiol Rev. 2001;14:336-363.</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Pauwels R., Verschraeger R., van der Straeter M. IgE antibodies to bacteria in patients with bronchial asthma. Allergy. 1980;35:665-669.</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Ishrag AA. Study Specific Immunoglobulin E.G. and Bacterial which induced Asthmatics. J. Natur Sci Res. 2015;5:21-25.</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Hales BJ, Martin AS, Pearce IJ, Rueter K., Zhang G., Khoo SK et al. Anti-bacterial IgE in the antibody responses of house dust mite allergic children. Clin Exp Allergy. 2009;39:1170-1178. DOI: 10.1111/j.1365-2222.2009.03252x.</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Bachert C., Zhang N., Holtappels G., De Lobel L., van Cauwenberge P., Liu et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J. Allergy Clin Immunol. 2010;126:962-968. DOI: 10.1016/j.yaci.2010.07.007.</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Kim SH, Yang SY, You J., Le SB, You J., Chang YS et al. Association of specific immunoglobulin E. to Staphylococcal enterotoxin with airway hyperresponsivenes in asthma patients. Tuberc Respir Dis. 2016;79:295-301.</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Hales B., Chai L., Elliot CE, Pearce LJ, Zhag G., Heinric TK et al. Antibacterial antibody responses associated with the development of asthma in house dust mite-sensitised and nonsensitised children. Thorax. 2012;67:321-327. DOI: 10.1136. thoraxjnl-2011-200650.</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Louis R., Djukanovic R. Is the neutrophil a worthy target in severe asthma and chronic obstructive pulmonary disease? Clin Exp Allergy. 2006;36:563-567.</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Dworski R., Simon HU, Hoskins A., Yousefi S. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J. Allergy Clin Immunol. 2011;127:1260-1266.</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Simpson JL, Grissel TV, Douwes J., Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007;62:211-218.</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Pham DL, Ban GY, Kim SH, Shin YS, Ye YM, Chwae YJ, Park HS. Neutrophil autophagy and extracellular DNA traps cjntribute to airway inflammation in severe asthma. Clin Exp Allergy. 2017;47:57-70. DOI: 10.1111/cea.12859.</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Федосеев ГБ, Коровина ОВ, Тенигина НГ Комплексная диагностика различных клинико-патогенетических вариантов бронхиальной астмы. Тер Арх. 1977;6:51-55</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Федосеев ГБ, Хлопотова Г.П. Бронхиальная астма. Л., «Медицина». 1988:269</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Федосеев ГБ, Трофимов ВИ, Шапорова НЛ, Александрин ВА, Филиппова НА, Крякунов К.Н. В. поисках истины: что такое бронхиальная астма? Пульмонология. 2015;25:5-18</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Hogg JC. A brief review of chronic obstructive pulmonary disease. Canadian Respiratory Journal. 2012;19:381-384.</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Fletcher C., Peto R. The natural history of chronic airflow obstruction. British Medical Journal. 1977;1:1645-1648.</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Wang L., Hao K., Yang T., Wang C. Role of the lung microbiome in the pathogenesis of chronic obstructive pulmonary disease. Chin Med J. (Eng.). 2017;130:2107-2111. DOI: 10.4103\0366-6999.211452.</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>King P., Sharma R. The lung immune response to nontypeable Haemophilus influenzae (Lung immunity to NTHi). J. Immunol Res. 2015. DOI: 10.1155/2015/706736.</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Rossel A., Monso E., Soler N., Torres F., Angrill J., Riise G. et al. Microbiologic of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165:891-897.</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>King PT, MacDonald M., Bardin PG. Bacteria in COPD; their potential role and treatment. Transl Respir Med. 2013;1:13. DOI: org/10.1187/2213-0802-1-13.</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation>Monso E. Microbiome in chronic obstructive pulmonary disease. Annals Trans Med. 2017;5(12). DOI: 10.21037/ atm.2017.04.20.</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation>Groutas W., Dou D., Allison KR. Neutrophil elastase inhibitors. Expert Open The Pat. 2011;21:339-354.</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation>Finkelstein R., Flaser RS, Ghezzo MG, Cosio VG. Alveolar inflammation and its relation to emphysema in smokers. Am J. Respir Crit Care Med. 1998;152:1666-1672.</mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation>Owen CA. Roles of proteinases in pathogenesis of chronic obstructive pulmonary disease. Intl J. COPD. 2008;3:253-268.</mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation>Федосеев ГБ, Трофимов ВИ, Негруца КВ, Тимчик ВГ, Голубева ВИ, Александрин ВС и соавт. Что такое Overlap синдром (ACOS), диагностика и лечение. Российский Аллергологический Журнал. 2018;15:17-29</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation>Федосеев ГБ, Трофимов ВИ, Тимчик ВГ, Негруца КВ, Голубева ВИ, Горовнева ЕВ и соавт. Инфекционная и неинфекционная сенсибилизация больных бронхиальной астмой и хронической обструктивной болезнью легких. Российский Аллергологический Журнал. 2015;6:39-53</mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation>McIvor RA Emerging therapeutic options for the treatment of patients with symptomatic asthma. Annals Allergy Asthma Immunol. 2015;115:265-271.</mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation>Lommatzsch M., Virchow C. Severe Asthma: Definition, Diagnosis and Treatment. Dtsch Arztebl. 2014;111:847-855.</mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation>Федосеев ГБ, Трофимов ВИ, Петрова М.А. Многоликая бронхиальная астма. СПб., Нордмедиздат. 2011:343</mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation>Gold, 2017. Arch. Bronchopneumol. 2017;53:128-149.</mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation>Which asthma patients should get the pneumococcal vaccine? J Fam Pract. 2009;58:611-612.</mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation>Talbot TR, Harlert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA et al. Asthma as a risk factor for invasivt pneumococcal disase. New Engl J Med. 2005;352:2082-2090.</mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation>Streptococcas colonization in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine. BMC Infections Diseases. 2016;16:12-26.</mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation>NewsonL.2017.https://translate googleusercontent.com/ translate_c?вузер=1&amp;h1=ru&amp;prev=search&amp;rur.</mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation>Froes F, Roche N, Blasi F. Pneumococcal vactination and chronic respiratory diseases. Int J of COPD. 2017;12:3457-3468.</mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation>Earl CS, Shi-qi An, Ryan RP The changing face of asthma and its relation with microbes. Trends Microbiol. 2015;23:408-418.</mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation>Sokolowska M, Frei R, Lunjanj N, Acdis CA, Mahony L. Microbiome and asthma. Asthma Res Pract. 2018;4:1. DOI: 10.1186/s40733-017-0037y.</mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation>Bieber T, Akdis C, Lauener R, Traidl-Hoffmann C, Scmid-Grendelmeier P, Schappi G et al. Global allergy forum and 3rd Davos declaration 2015: atopic dermatitis/eczema: challenges and opportunities toward precision medicine. Allergy. 2016;71:588-592. DOI: 10.1111/all.12857.</mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation>Lee SC, Yang YH, Huang SY Pan WH. Reduced medication use and improved pulmonary function with supplements containing vegetable and fruit concentrate, fish oil and probiotics in asthmatic school children a randomized controlled trial. Br J Nutr. 2013;110:145-155.</mixed-citation></ref></ref-list></back></article>
